Grant: Emerging Team Grant: From Genes to Proteins, Cells, Tissues and Patients - LOI
McGill University
$0.00
Vitamin B12 in Health and Disease
EF 2008-09
Résumé
Our ambitious and innovative proposal on vitamin B12 aims to enhance translation of gene and protein research to medicine. It will generate new knowlege about inherited diseases involving this important vitamin and apply insights to common problems involving patients and populations. More specific objectives include studies on how gene products interact using a variety of technologies derived from microbiology and protein science. We will exploit mouse models to study birth defects and the effect of treating mothers during pregnancy on preventing developmental abnormalities. Using small molecule screeing, we aim to identify compounds that can bind proteins of choice, enabling exploration of specific metabolic pathways and targeted therapeutic approaches.
Programme
Emerging Team Grant: From Genes to Proteins, Cells, Tissues and Patients - LOI
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
174427
Name
Rosenblatt David S
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Emerging Team Grant: From Genes to Proteins, Cells, Tissues and Patients
Projecttitle
Vitamin B12 in Health and Disease
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$0
Cihrequipment2
$0
Programname2
Emerging Team Grant: From Genes to Proteins, Cells, Tissues and Patients - LOI
Keyworddelim
Animal Models; Inborn Errors Of Metabolism; Protein Structure And Function; Small Molecule Screening; Vitamin B12
Abstract
Our ambitious and innovative proposal on vitamin B12 aims to enhance translation of gene and protein research to medicine. It will generate new knowlege about inherited diseases involving this important vitamin and apply insights to common problems involving patients and populations. More specific objectives include studies on how gene products interact using a variety of technologies derived from microbiology and protein science. We will exploit mouse models to study birth defects and the effect of treating mothers during pregnancy on preventing developmental abnormalities. Using small molecule screeing, we aim to identify compounds that can bind proteins of choice, enabling exploration of specific metabolic pathways and targeted therapeutic approaches.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rosenblatt, David S
Approvedterm
1 an 0 mois